Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_assertion type Assertion NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_head.
- NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_assertion wasGeneratedBy ECO_0000203 NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_provenance.
- NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_assertion wasDerivedFrom befree-20140225 NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_provenance.
- NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_assertion SIO_000772 10545285 NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_provenance.
- NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_assertion evidence source_evidence_literature NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_provenance.
- NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_assertion description "[If BLP ligand-receptor systems are to be targeted therapeutically in NSCLC, it will be necessary to inhibit both NMB and GRP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP450411.RACnBTxZmDpOHYe_3sQxbhsNS4hN2lRmDeaE4FepdKnVA130_provenance.